Fig. 3: Survival according to tumor-response to neoadjuvant therapy assessed by different scoring systems. | Modern Pathology

Fig. 3: Survival according to tumor-response to neoadjuvant therapy assessed by different scoring systems.

From: A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response

Fig. 3

Kaplan–Meier curves depicting 5-year overall survival (A, B, E, F) and 5-year disease-free survival (C, D, G, H) according to non-adapted MPR (A)–(C) or prognostic score (E)–(G) and adapted MPR (B)–(D) or prognostic score (F–H).

Back to article page